Medical News

• share
• favorite_border

Among young adults who frequently use cannabis, drinking alcohol is linked to intensified cannabis cravings in men and reduced cannabis cravings in women, a novel study suggests. The findings potentially illuminate mechanisms driving the combined use of the two substances and could inform sex-specific approaches to preventing or addressing the resulting harms. Young adults commonly use alcohol and cannabis together (i.e., co-use), and people who use both substances experience more negative consequences—including worse outcomes for alcohol use disorder treatment—than those who use one or the other. Co-use may be partially driven “cross-substance-induced” craving, in which the repeated co-use of two substances prompts one to become a trigger for the other. Research on this effect involving alcohol and cannabis—previously limited to laboratory testing and remote monitoring—has hinted at sex differences in these effects. For the study in Alcohol: Clinical Experimental Research, investigato

• share
• favorite_border

Pilot intervention looks at ways to bridge gaps in survivorship care, empowering young Latino men to manage distress and reclaim meaningful life goals after cancer treatment.

• share
• favorite_border

Alcohol use was the most common predictor of escalating cannabis vaping among youth and young adults, independent of demographic factors, according to research by UTHealth Houston published this month in the journal Social Science & Medicine.

• share
• favorite_border

The Johns Hopkins School of Nursing has established a Center for Equity in Child and Youth Health and Wellbeing.

• share
• favorite_border

Recovery Legal Care, a UChicago Medicine program designed to help survivors of violent crime, received funding from the NIH to study how free civil legal aid affects patients' long-term health and safety.

• share
• favorite_border

Wayne State University's Center for Emerging and Infectious Diseases (CEID) is launching its participation in World AMR Awareness Week with an urgent message: the growing threat of antimicrobial resistance requires immediate community action, so it is critical to educate, advocate, and act now.

• share
• favorite_border

A quadriplegic for the past 11 years, Julissa Santiago is the master of her own comfort. With the precision of a polite drill sergeant, she delivers instructions at bedtime for a series of minute body...

• share
• favorite_border

Some people with epilepsy also experience memory and learning issues, as well as depression or anxiety. A study in Australia screened people for these conditions at a seizure clinic, before anti-seizure medications had been prescribed. Compared with the control group, the people at the first seizure clinic had higher rates of cognitive and neuropsychological issues.

• share
• favorite_border

Prostate cancer is the second most commonly diagnosed cancer in men (behind skin cancer), with varying levels of aggressiveness. It’s also the second leading cause of cancer death, behind only lung cancer. A new study led by Yale Cancer Center researchers at Yale School Medicine found a substantial increase in the adoption of active surveillance (AS) and watchful waiting (WW) treatment strategies over the past decade — an encouraging trend for men seeking less invasive treatment options.

• share
• favorite_border

Epilepsy with eyelid myoclonia is a generalized epilepsy syndrome characterized by eye-closure-induced seizures or changes on the EEG, eyelid myoclonia--jerks of the eyelids and eye-rolling--with or without absence seizures, and photosensitivity. It appears predominantly in females and usually starts between the ages of 3 and 12.

• share
• favorite_border

• share
• favorite_border

Potentially deadly mathematical errors are prevalent among mobile applications used in clinical and emergency room settings, but a team of researchers at New Jersey Institute of Technology's Ying Wu C...

• share
• favorite_border

ACSM Announces New CEO

• share
• favorite_border

Since older adults have been more severely affected by acute COVID-19, researchers have hypothesized that older adults may have worse long COVID symptoms as well.

• share
• favorite_border

PREZADA MAYO CLINIC: Sou uma pessoa que busca agradar os outros por natureza e tenho dificuldade em dizer não ou estabelecer limites em meus relacionamentos. Como posso começar a criar limites mais saudáveis de uma maneira gentil, mas firme?

• share
• favorite_border

ESTIMADA MAYO CLINIC: Soy una persona que busca complacer a los demás por naturaleza y me cuesta decir no o establecer límites en mis relaciones. ¿Cómo puedo comenzar a crear límites más saludables de una manera amable pero firme?

• share
• favorite_border

A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions such as irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD), which affect millions of people worldwide. The research results were recently published in the international edition of the renowned journal Angewandte Chemie.

• share
• favorite_border

Since older adults have been more severely affected by acute COVID-19, researchers have hypothesized that older adults may have worse long COVID symptoms as well. But according to new research published in the Annals of Neurology, an official journal of the American Neurological Association, Northwestern Medicine researchers found on an average of 10 months after COVID-19 onset, younger (ages 18-44) and middle-aged (ages 45-64) adults had worse neurologic symptoms of long COVID than adults 65 and older. Symptoms included headache, numbness and tingling, problems with smell and taste, blurred vision, depression, anxiety, insomnia, fatigue and a decrease in cognitive function. These symptoms occurred regardless of if the patient had mild or severe COVID-19 infections.